chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the 1st dose, I felt a little light headed, chills, a little sore arm and I did experience some anxiety and felt a little off for 2-3 weeks. After the 2nd dose (Lot 028L20A on 2/4/2021 IM LA), I did not have the symptoms like the 1st dose. After a couple of weeks, I had a flare up of  tendonitis. My left knee had swelling on the outside and top, tenderness and swelling on top of the knee and inflammation in my tendons. My right knee also had swelling that may have been exacerbated from the vaccine.
About 12 hours after I got the second dose I stated to have a fever which progressed into one of the worst migraines I ever had. I was in so much pain and was vomiting and couldn?t keep any fluids down. I had to go to the ER to get an IV with drugs to rehydrate and get rid if the headache and nausea. One of the most painful nights of my life.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), on 13Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Other medication in 2 weeks: No. Treatment for covid-19 started on 09Dec2022, stop date: Dec2022. No known allergies. Other medical history: None.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Immediately after shots administered, he turned red in limbs and face. Lasted about 10 minutes then resolved. This reaction did not happen with last set of shots.
Left leg weakness, heaviness, tingling to left foot and toes. Bilateral lower leg pain with slight limp
On July 25th, Suddenly, I got a spider web in my right eye, no pain. It happened Saturday but I waited until Monday July 27th to go to the doctor, but I called an emergency doctor and I described what happen and he said to wait to Monday and then on Monday at 3:00PM I went to the eye center and the doctor said that it was a "Posterior vitreous detachment"; now the doctor has to monitor the eye, it is a possibility that my retina is damaged. It was a blood in my eye and probably that was the reason of the vitreous detachment. My next appointment is next Monday August 1st.
Patient was administered the first dose in the Pfizer COVID vaccine series. During the observation portion, the patient passed out in the observation area approximately 10 minutes after receiving the dose and became non-responsive with ragged breathing. The pharmacy team responded and administered a dose of epinephrine 0.3mg to the patient immediately and called for EMS who arrived on the scene
Information has been received from a pharmacist and a medical assistant via a company representative referring to two unspecified patients of unknown age and gender. There was no information about pertinent medical history or drug reaction/allergies reported. On unknown dates the patients were vaccinated with a dose of PNEUMOVAX23 (lot # L003188, expiration date 06-JUL-2016, route and dose were unknown). No concomitant medication was reported. On unknown dates the patients experienced redness, warmth and scoreness at injection site. The patients were seen by an unspecified healthcare provider to seek medical attention. The action taken with PNEUMOVAX23, outcome of the event and causality were unknown. This report is one of two reports from the same reporter. Additional information has been requested.
Abrupt onset (10-12 hours) post vaccine fever.  104 T max.  Fever lasted 48 hours, then abruptly stopped, and a lacy red rash appeared head to toe.
had the same reaction but with cotton wood trees pollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (005570).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "had the same reaction but with cotton wood trees pollen".  Additional information: I recently received your vaccination shots. I have found an interesting reaction that occurs. When a vaccinated person encounters an allergen, in my case mold, the vaccine appears to attack the allergen. I encountered mold days after my 2nd shot. My reaction started as hay fever, which is normal, but within 2 days I developed a fever. It's as if the vaccine was trying to rid me of the allergen by attacking it. I have a friend who has had the same reaction but with cotton wood trees pollen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A report was received from a healthcare professional in the USA on 6/25/04 concerning a 45 year old female vaccinee. No details were provided regarding the vaccinees medical history or whether she was taking any other medications. In October 2003, the vaccinee received an IM injection of Fluvirin. At an unspecified time after vaccination, the vaccinee developed a frozen shoulder syndrome, which she attributes to the Fluvirin. She is now receiving physical therapy for this problem. Further information will be sought. Follow up received on 15Nov04 from a health care professional in the US. The vaccinee has been identified as a 59 year old female who experienced frozen shoulder syndrome and injection site oedema after receiving and Fluvirin vaccination (batch 765753) in her left deltoid on 22Oct03. The vaccinee still experiences frozen shoulder syndrome, despite being provided with long term physical therapy treatment. The vaccinee has continued reduced mobility and pain 13 months after vaccination. The vaccinee's medical history includes C-section in 1982 and an allergy to anaestetic during the operation. She also has an allergy to penicillin since childhood and macrolides since the age of 55. Her concomitant medications include Hydrochlorothiazide, 25mg daily, for high blood pressure. The reporter considers the reaction serious due to disability and the vaccinee has been advised against influenza vaccination in the future.
After 5 days, the area where I got the shot there was  knot and a red ring around the vaccination site. My arm still felt tender. After researching, I learned I had "COVID arm". I had fatigue as well.
(L) facial edema x 30 min, 30 min after injection 40 after injection -> HA, dizzy, nausea.
Contracted COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted COVID). At the time of the report, COVID-19 (Contracted COVID) outcome was unknown.            No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.  Patient received Moderna shots and a Moderna booster but contracted COVID, with mild cold-like symptoms.   Company comment; This case concerns a patient of unknown age, with no medical history reported, who experienced the unexpected non serious event COVID 19. The event occurred after the third dose of mRNA-1273. As reported patient received Moderna shots and a Moderna booster but contracted COVID, with mild cold-like symptoms. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a patient of unknown age, with no medical history reported, who experienced the unexpected non serious event COVID 19. The event occurred after the third dose of mRNA-1273. As reported patient received Moderna shots and a Moderna booster but contracted COVID, with mild cold-like symptoms. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report.
redness swelling from rt shoulder to rt elbow;mom called then brought child in;+movement;increased redness & swelling to same area;sl edema noted;rt posterior shoulder blade area;
Tired; sore arm; A spontaneous report was received from a consumer concerning a 74 years old, female patient who experienced Sore arm/vaccination site pain and tiredness/Fatigue.    The patient's medical history included Osteopenia. Products known to have been used by the patient, included Muscle relaxant, medicine for reflux and osteopenia.   On 05 JAN 2021 the patient received the first of two planned doses of mRNA-1273 (Batch number: 011L20A) intramuscular in left arm for prophylaxis of COVID-19 infection.  On 03 FEB 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: 030L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    After the first dose of vaccination on 05-JAN-21, patient experienced side effects from 06 Jan 2021 to 07 Jan 2021 like sore arm.   She stated that she did not feel the needle when administered. After the second dose on 03 Feb 2021, she experienced sore arm and tiredness. This time she felt the needle during administration.   Treatment information was not reported.   Action taken with the drug in response to the event(s) was not applicable.  The event(s), Sore arm and fatigue was unknown and product administration error was recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I noticed a lump in my left breast. I called my doctor and she had me go in and get it checked. It went away. It proved to be an inflamed lymph node. It was gone in 3-5 days.
Patient reports pain, swelling that started a couple of days after the vaccination and has persisted until today 6/19/19 when he reported I to me.
This medically confirmed spontaneous report (initial receipt-29-Dec-2014) concerns a patient of unknown demography. The patient had a concurrent condition of human immunodeficiency virus which was contributing to death but not resulting in the underlying cause of death. On 12-May-2014, the patient received influenza virus vaccine (manufacturer and batch number not reported). On 30-Nov-2014, the patient died due to metastatic esophageal carcinoma. The Medical Examiner or Coroner was contacted. The outcome was reported as fatal. Reporter comments: It was unknown if tobacco contributed to death. The manner of death was natural.
On 8/6/2020  c/o pain in area of the muscle on the left arm where her injection was placed. Pt had normal ROM with some discomfort. Referral to physical therapy.
Pt received 2nd dose Moderna COVID-19 vaccine this morning at 0805. At 0820 she complained of feeling hot and nauseous and was given a bottle of water.  Then complained of feeling itchy all over. She stated she was very itchy and nauseous after 1st COVID vaccine but that this happened about 24 hours after her injection last time. She reported she did not take any medicine so far today. Was given diphenhydramine 50mg po at 0824. At 0829 Pt stated her throat felt like it was tightening and 911 was called. She then began coughing and self-administered albuterol inhaler x 2 puffs (Hx of asthma) while waiting for EMS. She was transported by fire to hospital for possible anaphylaxis. Pt was stable and responsive with open airway at time of transport.
mom unsure of temp stated felt extremely hot about 9o'clock started screaming/crying-stiffen arms & legs jerk lasting few seconds off & on till 5MAy93 AM; phoned MD; erythema/edema @ inject site approx 4" circular diameter;
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Fever-Severe, Error: Infection / Cellulitis (diagnosed by MD)-, Additional Details: Fever of 102 degrees Fahrenheit
chest pain; heart attack; headache; blood pressure was high; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28Mar2021 09:15 at single dose in left arm for COVID-19 immunization. Medical history included Irregular heart beat. The patient had no Allergies to medications, food, or other products. Concomitant medications included acetylsalicylic acid (BAYER ASPIRIN), and metoprolol. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On Monday morning (29Mar2021 06:45), when the patient got out of bed she started having chest pain, took a shower and the pain got worse like she was having a heart attack, she was admitted to the hospital and treated for the pain and had EKG, stress test done, blood pressure was high, and she had a very bad headache; The events resulted Emergency room/department or urgent care. Tuesday morning (30Mar2021) the pain started to decreased and after another EKG and her blood pressure went down she was released and advised to follow up with her primary doctor as well as the cardiologist. Lab test included Nasal swab negative on 29Mar2021. Treatment was received for all events. The outcome of all events was resolved.  Information on the lot/batch number has been requested.
Patient got a fluid filled blister at (Rt) site of injection site, swelled x 1 day. After that resolved.
got the shot, a couple of years later got shingles again; shingles; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The patient self reported the case. The age at vaccination was not reported. The patient stated, he/she got shingles, then got the shot and couple of years later got shingles again. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
first dose 16Jul2021 and second dose 26Aug2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number KF4T7, expiry date 14th November 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 26th August 2021, the patient received the 2nd dose of Shingrix. On 26th August 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The pharmacist reported that, the patient received 2nd dose of Shingrix, late than the recommended time interval, which led to shortening of vaccination schedule. The pharmacist stated patient was not immunocompromised. Both doses were administered at the same facility.  The pharmacist provided lot number of GL79C for first dose but did not have expiration date. The reporter consented to follow up.
This spontaneous report was received from a registered nurse and refers to a 16 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-JUL-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N001528 with expiry date: 13-JAN-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.
covid infection; covid infection; This is a spontaneous report received from a contactable reporter(s) (Nurse).  An adult patient received BNT162b2 (BNT162B2), on 19Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Jan2023, outcome "recovering" and all described as "covid infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Jan2023) Positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  Clinical course: If other vaccine in four weeks: Unknown. if treatment ae: No. If covid prior vaccination: Unknown. If covid tested post vaccination: Yes.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Pt is allergic to pcn. Hence I asked her to wait 30 mins after the 1 st covid vaccine. 20 mins later, pt started developing itching on her legs and body. I gave her 25 mg liquid benadryl. I asked mom to stay for longer time just to make sure it wouldnt lead to anything else.After about another 15 mins later, she started having difficulty breathing. Pt is a minor, with moms approval called 911 and also administered epipen ( pt weighs 120 lbs per mom ) . First responders came. hr was 72, bp 122/68. She was visibly jittery from the shot, but she was able to breathe
bell's palsy; This is a spontaneous report. A contactable consumer(patient) reported that a patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on Jun2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced bell's palsy and was told by urgent care to go to the emergency room. Outcome of event was unknown.   The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
PATIENT FAINTED AND FELL TO THE GROUND  COUPLE OF MINUTES AFTER RECEIVING HER VACCINATION. SHE HAD SEIZURES ASSOCIATED WITH SYNCOPE.
Vaccines were stored in the fridge on 30Jun2021 and administered on 16-Aug-2021; No adverse event; 40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored), PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 16-Aug-2021) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 16-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 16-Aug-2021) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored), PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 16-Aug-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored) and PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 16-Aug-2021).    No concomitant and treatment medications were reported.  Reported that 40 patients received the Moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge. Vaccines were stored in the fridge on 30Jun2021, there are different administration dates, starting on 02Aug2021 until 20Sep2021 being the last one. Patients did not report any side effects.   This case reported for patient 13 of 31 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-698994 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698994:Master case
Received pneumococcal vaccine in left deltoid 3/15/10. On 3/18/10 noted red macular rash (about 6 lesions) on left arm. No other symptoms. No other explanation for macular rash. Resolved by 3/19/10.